Omios Biologics
PrivateLast Round
Pre Seed
Oct 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Omios Biologics is a biotechnology company developing next-generation oncolytic virus immunotherapies to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omios Biologics Comparables
Compare Omios Biologics with similar companies based on industry and business-model similarity.
Omios Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 1, 2025 |
Omios Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FuturePlay | Pre Seed |
| NYU Innovation Venture Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Led by FuturePlay and NYU Langone Health Venture Fund.
Omios Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Omios Biologics's valuation, stock price, and market status.